OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 321 - 330 of 764 studies

Eye

Eye2Gene: accelerating the diagnosis of inherited retinal diseases

Inherited retinal disease (IRDs) are a leading cause of visual impairment in the working age population. Mutations in over 300 genes are associated with IRDs and a genetic diagnosis, which involves identifying the affected gene in a patient, is the first step towards care and management of the patient. However, genetics diagnosis is currently slow, expensive and not widely accessible: - Average time to diagnosis is over 5 years and costs £10,000 per patient. - More than 40% of patients are ...

GO TO STUDY Go

Cancer and neoplasms

Meso-ORIGINS: Mesothelioma Observational study of RIsk prediction and Generation of benign-meso tissue pairs, Including a Nested MRI Sub-study

Malignant pleural mesothelioma (MPM) is an incurable cancer of the lining of the lung, which is strongly associated with prior asbestos exposure. MPM typical develops after decades of asbestos-driven benign pleural inflammation and it is not known what triggers the evolution from benign inflammation to MPM, or how best to treat the cancer to reverse or halt these processes. Meso-ORIGINS forms the prospective tissue collection element of the PREDICT-Meso International Accelerator Network funded by CRUK/AIRC/AECC. Our aim is to generate a large prospective cohort of ...

GO TO STUDY Go

Neurological

Adult SMA REACH: Development and implementation of a standardised data set and data collection research study in the UK Adult SMA population

Adult SMA REACH is a project created to capture natural history data on adult patients with spinal muscular atrophy (SMA). SMA is a rare form of motor neuron disease caused by mutations in the survival motor neuron 1 gene (SMN1) and which affects both children and adults. In recent years, the field has seen a dramatic change in available treatments for this cohort of patients. Adult SMA REACH has established a clinical network of health professionals from clinical sites across ...

GO TO STUDY Go

Reproductive health and childbirth

Perception Ultrasound for Reassuring Fetal Echo Clinical Trainees (PURFECT)

Ultrasound is a mandatory tool for safely monitoring the growth and development of foetuses during pregnancy. Although pregnancy ultrasound is routinely used in developed countries, it has a major disadvantage, namely a high level of operator dependence: non-experts (or infrequent) users of the technology are often not able to acquire and interpret diagnostic ultrasound images consistently and reliably. Consequently, there is a significant requirement for training, and lack of adequately trained staff is the most commonly reported barrier to the ...

GO TO STUDY Go

Cancer and neoplasms

The FINESSE Study: A randomised phase 3 trial evaluating the role of Finasteride in increasing compliance with Active surveillance, in men with a new diagnosis of low and intermediate risk prostate cancer, when compared with usual care.

Prostate cancer is the commonest cancer in men. Many prostate cancers are not lethal and can be safely managed by observation (Active Surveillance). Over time,more than half of the men choosing observation receive radical surgery or radiotherapy. Both treatments produce side effects and may be unnecessary. Most men opt for treatment because of their rising PSA (prostate blood test) levels. This usually reflects aging of the prostate,rather than advancing cancer. We aim to improve what is offered,so more men remain on ...

GO TO STUDY Go

Cancer and neoplasms Metabolic and Endocrine

Dissecting the Contribution of glucocorticoid metabolism in Mild Autonomous Cortisol Secretion: a randomised controlled trial of the 11β-HSD1 inhibitor SPI-62 (DC-MACS)

We will conduct a randomised,double-blind,placebo controlled,Phase 2 study to evaluate the effect of the selective 11β-HSD1 inhibitor,SPI-62,6mg once daily for 12-weeks,on metabolic,bone and cognitive phenotype in patients with adrenal adenomas and evidence of MACS. 40 patients with MACS will be recruited from tertiary referral endocrine centres. All participants will have baseline investigations performed before treatment. We will collect clinical data by collecting biological samples including serum,urine,adipose tissue and microdialysis,as well as questionnaires and cognitive function tests. All participants will have baseline ...

GO TO STUDY Go

Stroke

Investigating consolidation of motor learning in the context of recovery after stroke (SMiLES)

Rehabilitation of movement after stroke depends on motor learning. Motor learning involves not only improvement during practice but also improvement between sessions, known as consolidation. Consolidation of learning depends on good sleep quality. However, there is growing evidence that sleep is disrupted after stroke and we recently showed that following brain injury, patients with poorer sleep show worse rehabilitation outcomes. This might occur because sleep disruption impairs consolidation directly, or might reflect other factors that influence both sleep and clinical ...

GO TO STUDY Go

Cancer and neoplasms

DETERMINE (Determining Extended Therapeutic indications for Existing drugs in Rare Molecularly defined Indications using a National Evaluation platform trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers with Actionable Genomic Alterations, including Common Cancers with Rare Actionable Alterations. (DETERMINE)

The overall aim of the trial is to evaluate the efficacy of licensed targeted therapies in unlicensed indications,in rare adult,paediatric and TYA cancers with actionable genomic alterations (including common cancers with rare actionable alterations) and to identify genomic,transcriptomic and immune contextual influences on response to therapy. The ultimate aim is to transition positive findings ...

GO TO STUDY Go

Cancer and neoplasms

PRiZM+: A phase II platform study of zanubrutinib monotherapy and combination therapy for relapsed and refractory primary CNS lymphoma (PRiZM+)

Primary central nervous system lymphoma (PCNSL) is a rare type of brain tumour. It is an aggressive type of non-Hodgkin lymphoma that is found only in the brain or spinal cord. PCNSL is often treated with high-doses of chemotherapy. The first treatment doesn’t work for some patients (called ‘refractory’), and the lymphoma can come back (called ‘relapse’). Refractory or relapsed (RR) PCNSL is much more difficult to treat. There is currently no standard treatment for RR-PCNSL and further chemotherapy ...

GO TO STUDY Go

Neurological Reproductive health and childbirth

The OPTIMISE:MS Pregnancy Registry – A Real World Pregnancy Pharmacovigilance Study

This is a pragmatic, a non-interventional, prospective observational cohort study planned to run for 6 years (Includes pregnancy and to the child’s 5th birthday). This study will build on the infrastructure formed as part of the main OPTIMISE:MS study, adding pregnancy-focused pharmacovigilance. Due to the need to contact healthcare providers for information over and above that recorded in the neurological records, this study needs additional approvals to the main study. The pregnancy study will meet the needs ...

GO TO STUDY Go